Strategies to delay progression of established renal disease have primarily been directed at examining the class of antihypertensive therapy and/or the level of blood pressure control. In diabetic renal disease many trials have noted a protective role of ACE inhibitor-based therapy over non-ACE inhibitor-based therapy. This paper reviews recent clinical trials evaluating hypertension-related kidney disease including the interim results of the African-American Study of Kidney Diseases and Hypertension (AASK) Study, to date the largest prospective study of African-American patients with kidney disease due to hypertension. This trial reports a renoprotective effect of ACE inhibitor-based therapy over calcium-channel antagonist- based therapy. The renoprotective effect of ACE inhibitor-based therapy may, in part, be due to their antiproteinuric effect independent of blood pressure lowering.
Preventing Renal Dysfunction in Patients with Hypertension : Clinical Implications from the Early AASK Trial Results. Publishing Authors By Initials
Preventing Renal Dysfunction in Patients with Hypertension : Clinical Implications from the Early AASK Trial Results. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: American journal of cardiovascular drugs : drugs,
VOLUME: 3
Page Numbers: 193-200
Journal Abbreviation:
ISSN: 1175-3277
DAY: 19
MONTH: 01
YEAR: 2003
Preventing Renal Dysfunction in Patients with Hypertension : Clinical Implications from the Early AASK Trial Results. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 100967755
Preventing Renal Dysfunction in Patients with Hypertension : Clinical Implications from the Early AASK Trial Results. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Preventing Renal Dysfunction in Patients with Hypertension : Clinical Implications from the Early AASK Trial Results. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Preventing Renal Dysfunction in Patients with Hypertension : Clinical Implications from the Early AASK Trial Results.
AFFILIATION: Emory University School of Medicine, Atlanta, Georgia, USA.
Country: New Zealand
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Am J Cardiovasc Drugs
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Preventing Renal Dysfunction in Patients with Hypertension : Clinical Implications from the Early AASK Trial Results Related Publications